openPR Logo
Press release

Depyrogenated Sterile Empty Vials Market 2019 Growth Research Report by 2025

01-13-2020 06:14 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

Depyrogenated Sterile Empty Vials Market

Depyrogenated Sterile Empty Vials Market

Depyrogenated sterile empty vials market trends are anticipated to witness a significant change over the coming years owing to increasing awareness among people about HIV and other infectious diseases. Several regions in the world are striving to bring the spread of HIV/AIDS under control. Governments are taking various measures to eradicate the spread of such infectious diseases and investing in research and development activities across the globe, which will substantially impel the industry outlook.

A worldwide increase in incidences of infectious diseases is expected to enhance depyrogenated sterile empty vials market growth. In 2017, there were approximately 36.9 million people across the globe living with HIV/AIDS – the number reached nearly 37.9 million in 2018. About 23.3 million people were going through antiretroviral therapy by the end of 2018. Approximately, 62% of people enduring HIV were getting treated with antiretroviral medication in the same year. Upsurge in awareness and treatment is likely to augment depyrogenated sterile empty vials market size over 2019-2025.

Get a Sample Copy of this Report@

Asia Pacific region had been estimated to have 5.2 million people living with HIV in 2017. China, India and Indonesia account for almost three-quarters of the total number of people living with HIV in the region. In 2017, 74% of people living with HIV in APAC region were aware of their infection.
Among those diagnosed with HIV, 71% were on treatment and 85% were virally suppressed. Around 2.7 million people living with HIV in the region were accessing antiretroviral treatment (ART) in 2017, up from 900,000 in 2010. Upsurge in number of patients being treated to control HIV will contribute considerable proceeds to depyrogenated sterile empty vials industry by 2025.
APAC depyrogenated sterile empty vials industry accounted for about 24% revenue share in the year 2018 and is projected to register a significant increase by 2025.

Many R&D activities have been initiated to cure infectious diseases like HIV. For instance, Merck had announced the results from a phase 2B clinical trial of investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), islatravir (MK-8591), for the treatment of HIV-1. A persistent necessity has been observed for additional efficient therapeutic regimens for the treatment of people enduring HIV-1, and islatravir has been affirmed for further trials.
Based on the Phase 2B data, the company has planned to start a phase 3 trial to evaluate islatravir in combination with doravirine. The phase 3 trial will be studied across diverse patient populations to report the evolving requirements of people living with HIV-1. Such R&D activities are also being promoted by governments to improve national health status which may influence depyrogenated sterile empty vials market growth.

Make an inquiry for purchasing this report @

The research-based pharmaceutical industry currently spends more than $149.8 billion on R&D per year. In 2015, 56 new medicines were rolled out, while currently over 7,000 compounds are at different levels of development globally. In 2014, there were 401 drugs in the pipeline for diabetes and 208 drugs in development for HIV/AIDS. Currently, IFPMA members have 119 ongoing R&D projects related to neglected tropical diseases. A huge number of clinical studies has led to increased injectables that will further augment depyrogenated sterile empty vials market growth.

Most clinical studies use more than 20 ml vials. In this context, it is prudent to mention that more than 20 ml product segment in depyrogenated sterile empty vials market was evaluated at more than $1.5 million in 2018. Current trends indicate that the segment will experience enormous growth over forecast period.

Instances of growth in APAC depyrogenated sterile empty vials market can be cited through the industry scenario in India. The Indian government has regulated policies which aim at promoting both public and private sector involvement in the R&D practice. With more and more multinational pharmaceutical companies setting up their R&D centers in India, the sector has seen an uptrend in investments in recent years.

In the year 2015, India was ranked as the country with the sixth largest annual R&D spending in the world, responsible for 3.53 percent of global R&D outgoings. R&D spending in India is anticipated to grow from 0.9 per cent to 2.4 percent of the country’s GDP from 2014 to 2034. Increasing demand and investments in R&D activities in pharmaceutical sector is anticipated to drive depyrogenated sterile empty vials industry in the times to come.

Browse Report Summary @

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary Paid sources Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Depyrogenated sterile empty vials industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. End-use trends
2.1.4. Regional trends
Chapter 3. Depyrogenated Sterile Empty Vials Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers Government policies to support innovative packaging in developing economies Increasing prevalence of infectious diseases across the globe Technological advancements Growing usage in compounding and clinical labs
3.3.2. Industry pitfalls and challenges Surging demand for other parenteral packaging alternatives
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By end-use
3.5. Porter’s analysis
3.6. Competitive landscape, 2017
3.6.1. Strategy dashboard
3.7. PESTEL analysis

More Insightful Info@

With considerable efforts towards R&D activities in pharma sector and spread of awareness regarding treatment of infectious diseases, depyrogenated sterile empty vials market will witness remarkable progress over 2019-2025. Reports estimate that depyrogenated sterile empty vials industry share will surpass $8 billion by 2025.

Related Reports:
Healthcare Cloud Computing Market:

Medical Electronics Market:

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depyrogenated Sterile Empty Vials Market 2019 Growth Research Report by 2025 here

News-ID: 1895061 • Views: 284

More Releases from Global Market Insights Inc.

Neopentyl glycol flakes market is expected to register 7% gains during the forec …
The neopentyl glycol market revenue is set to reach a valuation of $1.5 billion by 2025, according to a 2019 Global Market Insights, Inc. report. Rising demand for powder coatings applications in automotive, aerospace, electronics and construction industry is expected to boost the market size in forecasted time frame. Strong application scope in powder coating resins as an alternative to conventional resins with low VOC emission and enhanced durability supporting neopentyl
Fluorinated ethylene propylene films market revenue from solar panel application …
The fluorinated ethylene propylene market is poised to rise from USD 690 million in 2018 to over USD 1200 million by 2025, according to a 2019 Global Market Insights, Inc. report. Rising demand for high-value compact & small-sized cars and SUVs owing to a growing middle class and rising disposable incomes should stimulate market size. This product finds widespread usage in tubing, pressure hoses and bellows it is well-suited for processing
bentonite market size from foundry sand applications was valued at over 680 kilo …
Bentonite Market is expected to be valued USD 1.95 billion by 2024; according to a new research report by Global Market Insights, Inc. Booming steel industry in India, China and South Korea on account of increasing foreign direct investment from U.S. and Japan has boosted the iron pelletizing industry and may promote growth of bentonite market. The product is used as a binding agent, offer improved mechanical & abrasive strength, faster
Polyacrylamide Market is likely to reach $8 billion by 2026, Says Global Market …
According to the report published by Global Market Insights, Inc., the polyacrylamide market size is anticipated to hit $8 billion by 2026, registering a CAGR of 9% from 2019 to 2026. Expanding product demand as a flocculant and thickening agent for water treatment operations in various industries will aid industry growth. Rising demand for processing wastewater in industries and from municipal sources has resulted in the greater demand for polyacrylamide as

All 5 Releases

More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral